Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Pei Li Teh & Wan Ling Neo
  • April 16, 2020
  • Webinars

Too much choice? Cure the headaches of traditional conjoint with novel approaches

Too much choice? Cure the headaches of traditional conjoint with novel approaches

Watch this webcast in which quantitative experts Pei Li Teh and Wan Ling Neo outline some of the key limitations of traditional conjoint research and how to overcome them using novel approaches. 

read more »

  • Posted by Misti Paul
  • April 7, 2020
  • Blogs

COVID-19 and Artificial Intelligence

COVID-19 and Artificial Intelligence

Analytics Director Misti Paul takes a look at how organisations worldwide are employing AI to try and combat the virus.

As COVID-19 continues to spread all over the world, threatening to bring healthcare systems to their knees, there are now over 1.2 million cases reported worldwide and sadly over 70,000 deaths. At Research Partnership, we wanted to take a look at how organisations worldwide are employing AI to try and combat the Coronavirus: Baidu’s AI Team Open Sources LinearFold: The AI team at Baidu has released a tool, LinearFold, which reduces 2019-nCoV prediction time from 55 minutes to 27 seconds. This reduction in prediction time is crucial for understanding the virus and accelerate drug discovery. BlueDot Surveillance: A Toronto-based health surveillance company, BlueDot, is working towards making predictions on the spread of COVID-19 by gathering disease data from myriad online sources. Earlier last month they used airline flight information to make predictions about where infectious diseases may appear next, since air travel is a common vector in communicable diseases. AliBaba’s AI system: Alibaba’s Jack Ma claimed that its new AI system can detect coronavirus in CT scans of patients’ chests with 96% accuracy against viral pneumonia cases. In March, Alibaba sent their first consignment of 500,000 testing kits and 1 million masks to the US and consignments of supplies to…

read more »

  • Posted by Paula Coyle and Ellie Forde
  • March 31, 2020
  • Webinars

Agile is a mind-set not a methodology

Agile is a mind-set not a methodology

We’ve all heard about how important it is to be agile. And the focus in pharmaceutical market research has been mainly on speed, and the methodologies and techniques that get us faster results. But we believe there’s more to being agile than just toolkits and technology.

read more »

How an online market research community delivered fresh insights into a small and hard-to-reach audience

Often a short research study isn’t sufficient to get the level of insights and understanding that you require, especially when working with a hard to reach target audience. 

Our client needed to research an extremely small and difficult to reach audience in multiple markets across the globe in support of their new product in development. In addition to gaining a deeper market understanding, the client wanted to obtain qualitative and quantitative insights into topical questions as they arose. 
We created a market research online community platform for the client to be run across multiple markets for a year.

read more »

  • Posted by Anthony Greenwood
  • March 18, 2020
  • Blogs

COVID 19 and behavioural science

COVID 19 and behavioural science

The recent coronavirus outbreak is a clear concern for everyone. What has been interesting to me is how front and centre behavioural science has been in the government’s response to the ongoing crisis. In listening to the Prime Minister in his address to the UK nation on Monday it was noteworthy in his statements how, when he references the role of science in guiding their approach, he explicitly talked as much about behavioural science as he did about the science behind the disease. 

read more »